Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.005x

Based on the latest financial reports, Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) has a cash flow conversion efficiency ratio of 0.005x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥8.57 Million ≈ $1.25 Million USD) by net assets (CN¥1.62 Billion ≈ $236.85 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Zhejiang Shapuaisi Pharmaceutical Co Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Zhejiang Shapuaisi Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how Zhejiang Shapuaisi Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zhejiang Shapuaisi Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Shapuaisi Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
HL Corp Shenzhen SHE:002105	0.054x
Western New England Bancorp Inc NASDAQ:WNEB	0.023x
Ready Capital Corp NYSE:RC	0.232x
Microbio Co Ltd TWO:4128	-0.010x
Bank Multiarta Sentosa PT JK:MASB	0.033x
Hansol Technics KO:004710	0.037x
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd SHE:301126	N/A
Bold Eagle Acquisition Corp. Class A Ordinary Shares NASDAQ:BEAG	-0.001x

Annual Cash Flow Conversion Efficiency for Zhejiang Shapuaisi Pharmaceutical Co Ltd (2008–2024)

The table below shows the annual cash flow conversion efficiency of Zhejiang Shapuaisi Pharmaceutical Co Ltd from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see 603168 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.59 Billion ≈ $232.62 Million	CN¥25.67 Million ≈ $3.76 Million	0.016x	-32.69%
2023-12-31	CN¥1.73 Billion ≈ $253.06 Million	CN¥41.49 Million ≈ $6.07 Million	0.024x	-64.41%
2022-12-31	CN¥1.72 Billion ≈ $251.20 Million	CN¥115.72 Million ≈ $16.93 Million	0.067x	-9.54%
2021-12-31	CN¥1.35 Billion ≈ $197.91 Million	CN¥100.78 Million ≈ $14.75 Million	0.075x	+120.75%
2020-12-31	CN¥1.31 Billion ≈ $191.13 Million	CN¥44.09 Million ≈ $6.45 Million	0.034x	-15.48%
2019-12-31	CN¥1.49 Billion ≈ $217.89 Million	CN¥59.47 Million ≈ $8.70 Million	0.040x	-41.06%
2018-12-31	CN¥1.48 Billion ≈ $216.74 Million	CN¥100.37 Million ≈ $14.69 Million	0.068x	+146.44%
2017-12-31	CN¥1.66 Billion ≈ $242.51 Million	CN¥45.57 Million ≈ $6.67 Million	0.027x	-85.11%
2016-12-31	CN¥1.59 Billion ≈ $233.29 Million	CN¥294.33 Million ≈ $43.07 Million	0.185x	+44.05%
2015-12-31	CN¥891.62 Million ≈ $130.47 Million	CN¥114.27 Million ≈ $16.72 Million	0.128x	-33.93%
2014-12-31	CN¥762.90 Million ≈ $111.64 Million	CN¥147.99 Million ≈ $21.66 Million	0.194x	-41.85%
2013-12-31	CN¥353.31 Million ≈ $51.70 Million	CN¥117.86 Million ≈ $17.25 Million	0.334x	+35.99%
2012-12-31	CN¥274.21 Million ≈ $40.13 Million	CN¥67.27 Million ≈ $9.84 Million	0.245x	+227.15%
2011-12-31	CN¥201.95 Million ≈ $29.55 Million	CN¥15.14 Million ≈ $2.22 Million	0.075x	-35.10%
2010-12-31	CN¥152.04 Million ≈ $22.25 Million	CN¥17.57 Million ≈ $2.57 Million	0.116x	-56.11%
2009-12-31	CN¥109.67 Million ≈ $16.05 Million	CN¥28.87 Million ≈ $4.22 Million	0.263x	+120.01%
2008-12-31	CN¥93.58 Million ≈ $13.69 Million	CN¥11.20 Million ≈ $1.64 Million	0.120x	--

About Zhejiang Shapuaisi Pharmaceutical Co Ltd

SHG:603168 China Drug Manufacturers - Specialty & Generic

Market Cap

$278.66 Million

CN¥1.90 Billion CNY

Market Cap Rank

#15274 Global

#4499 in China

Share Price

CN¥5.09

Change (1 day)

+0.20%

52-Week Range

CN¥5.08 - CN¥8.67

All Time High

CN¥31.28